Article info
PDFOriginal research
Paediatric xenotransplantation clinical trials and the right to withdraw
- Correspondence to Dr Daniel J Hurst, Family & Community Medicine, UAB, Birmingham, AL 35042, USA; djhurst{at}uab.edu
Citation
Paediatric xenotransplantation clinical trials and the right to withdraw
Publication history
- Received July 1, 2019
- Revised October 11, 2019
- Accepted October 24, 2019
- First published November 8, 2019.
Online issue publication
May 14, 2020
Article Versions
- Previous version (8 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Ethics in a time of coronavirus
- Xenotransplantation
- Proceeding with clinical trials of animal to human organ transplantation: a way out of the dilemma
- Starting clinical trials of xenotransplantation—reflections on the ethics of the early phase
- Xenotransplantation: progress and promise
- Advance directives in psychiatric care: a narrative approach
- Knowledge of and attitudes toward clinical trials in Saudi Arabia: a cross-sectional study
- Porcine Islets as an Alternative to Human Islets for Transplantation
- Meeting the goal of concurrent adolescent and adult licensure of HIV prevention and treatment strategies
- Effectiveness of antitussives, anticholinergics or honey versus usual care in adults with uncomplicated acute bronchitis: a study protocol of an open randomised clinical trial in primary care